1. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q
- Author
-
Hamilton, Steven P., Fyer, Abby J., Durner, Martina, Heiman, Gary A., de Leon, Ada Baisre, Hodge, Susan E., Knowles, James A., and Weissman, Myrna M.
- Subjects
Panic attacks -- Causes of ,Panic attacks -- Genetic aspects ,Panic disorders ,Phenotype -- Genetic aspects ,Chromosomes -- Physiological aspects ,Chromosomes -- Genetic aspects ,Genetic research -- Analysis ,Science and technology - Abstract
Substantial evidence supports that there is a genetic component to panic disorder (PD). Until recently, attempts at localizing genes for PD by using standard phenotypic data have not proven successful. Previous work suggests that a potential subtype of PD called the panic syndrome exists, and it is characterized by a number of medical conditions, most notably bladder/renal disorders. In the current study, a genome scan with 384 microsatellite markers was performed on 587 individuals in 60 multiplex pedigrees segregating PD and bladder/kidney conditions. Using both single-locus and multipoint analytic methods, we found significant linkage on chromosome 22 (maximum heterogeneity logarithm of odds score = 4.11 at D22S445) and on chromosome 13q (heterogeneity logarithm of odds score = 3.57 at D13S793) under a dominant-genetic model and a broad phenotypic definition. Multipoint analyses did not support the observation on chromosome 22. The chromosome 13 findings were corroborated by multipoint findings, and extend our previous findings from 19 of the 60 families. Several other regions showed elevated scores by using when one analytic method was used, but not the other. These results suggest that there are genes on chromosome 13q, and possibly on chromosome 22 as well, that influence the susceptibility toward a pleiotropic syndrome that includes PD, bladder problems, severe headaches, mitral valve prolapse, and thyroid conditions.
- Published
- 2003